Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease

Cellular and Molecular Life Sciences

Volumn 62, Issue 7-8, 2005, Pages 769-783

  Masutani, M ^a   Nakagama, H ^a   Sugimura, T ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Autoimmune diseases; Cancer; PARG; PARP; Poly(ADP ribose)

Indexed keywords

5 IODO 6 AMINO 1,2 BENZOPYRONE; AG 14361; ANTIBODY; BENZAMIDE 4 HYDROXY QUINAZOLINE; BENZAMIDE DERIVATIVE; BENZENE DERIVATIVE; DNA; ENZYME INHIBITOR; GLYCOSIDASE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLY(ADENOSINE DIPHOSPHATE RIBOSE) ANTIBODY; POLY(ADENOSINE DIPHOSPHATE RIBOSE)GLYCOHYDROLASE; QUINAZOLINE DERIVATIVE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; AUTOIMMUNE DISEASE; CANCER; CANCER RADIOTHERAPY; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL DEATH; CHEMOSENSITIVITY; CHROMOSOME 10Q; DNA POLYMORPHISM; DNA REPAIR; ENZYME INHIBITION; EPIGENETICS; GENE MUTATION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; GERM CELL TUMOR; HAPLOTYPE; HASHIMOTO DISEASE; HETEROZYGOSITY LOSS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PROMOTER REGION; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSCRIPTION REGULATION;

ANIMALS; AUTOIMMUNE DISEASES; CELL DEATH; DNA REPAIR; ENZYME INHIBITORS; GENOMIC INSTABILITY; GLYCOSIDE HYDROLASES; HUMANS; MICE; NEOPLASMS; POLY ADENOSINE DIPHOSPHATE RIBOSE; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANS-ACTIVATION (GENETICS);

ANIMALIA;

EID: 18544386364     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-004-4509-x     Document Type: Review

References (109)

1. Purnell M. R. and Whish W. J. (1980) Novel inhibitors of poly(ADP-ribose) synthetase. Biochem. J. 185: 775-777
2. Masutani M., Nakagama H. and Sugimura T. (2003) Poly(ADP-ribose) and carcinogenesis. Genes Chromosomes Cancer 38: 339-348
3. Masutani M., Gunji A., Tsutsumi M., Ogawa K., Kamada N., Shirai T. et al. (2004) Role of poly-ADP-ribosylation in cancer development. In: Landes Bioscience Intelligence Unit Series, Poly(ADP-ribosyl)ation, Buerkle A. (ed.), Landes Bioscience/Eurekah.com, Georgetown, in press
4. Kanai Y., Kawaminami Y., Miwa M., Matsushima T. and Sugimura T. (1977) Naturally-occurring antibodies to poly(ADP-ribose) in patients with systemic lupus erythematosus. Nature 265: 175-177
5. Lichtenstein P., Holm N. V., Verkasalo P. K., Iliadou A., Kaprio J., Koskenvuo M. et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark and Finland. N. Engl. J. Med. 343: 78-85
6. Ohshima H., Tatemichi M. and Sawa T. (2003) Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417: 3-11
7. Ame J.C., Spenlehauer C. and de Murcia G. (2004) The PARP superfamily. Bioessays 26: 882-893
8. Ikejima M., Yamashita R., Ogura T., Sugimura T., Gill D. M. and Miwa M. (1990) The zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNA. J. Biol. Chem. 265: 21907-21913
9. Rolli V., Ruf A., Augustin A., Schuls G. E., Menissier-de Murcia J. and de Murcia G. (2000) Poly(ADP-ribose) polymerase: structure and function. In: From DNA Damage and Stress Signaling to Cell Death. PolyADP-Ribosylation Reactions, de Murcia G. and Shall S. (eds), pp. 35-79, Oxford University Press, New York
10. Lonskaya I. and Soldatenkov V. (2004) Structure-specific DNA binding of PARP-1. Proc. Am. Assoc. Cancer Res. 45: 532
11. Schreiber V., Ame J. C., Dolle P., Schultz I., Rinaldi B., Fraulob V. et al. (2002) Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J. Biol. Chem. 277: 23028-23036
12. Rolli V., O'Farrell M., Menissier-de Murcia J. and de Murcia G. (1997) Random mutagenesis of the poly(ADP-ribose) polymerase catalytic domain reveals amino acids involved in polymer branching. Biochemistry 36: 12147-12154
13. Sallmann F. R., Vodenicharov M. D., Wang Z. Q. and Poirier G.G. (2000) Characterization of sPARP-1. An alternative product of PARP-1 gene with poly(ADP-ribose) polymerase activity independent of DNA strand breaks. J. Biol. Chem. 275: 15504-15511
14. Meyer-Ficca M. L., Meyer R. G., Coyle D. L., Jacobson E. L. and Jacobson M. K. (2004) Human poly(ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding isoforms that localize to different cell compartments. Exp. Cell Res. 297: 521-532
15. Meyer R. G., Meyer-Ficca M. L., Jacobson E. L. and Jacobson M. K. (2003) Human poly(ADP-ribose) glycohydrolase (PARG) gene and the common promoter sequence it shares with inner mitochondrial membrane translocase 23 (TIM23). Gene 314: 181-190
16. Lin W., Ame J. C., Aboul-Ela N., Jacobson E. L. and Jacobson M. K. (1997) Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase. J. Biol. Chem. 272: 11895-11901
17. Shimokawa T., Masutani M., Nagasawa S., Nozaki T., Ikota N., Aoki Y. et al. (1999) Isolation and cloning of rat poly(ADP-ribose) glycohydrolase: presence of a potential nuclear export signal conserved in mammalian orthologs. J. Biochem. (Tokyo) 126: 748-755
18. Ohashi S., Kanai M., Hanai S., Uchiumi F., Maruta H., Tanuma S. et al. (2003) Subcellular localization of poly(ADP-ribose) glycohydrolase in mammalian cells. Biochem. Biophys. Res. Commun. 307: 915-921
19. Affar E. B., Germain M., Winstall E., Vodenicharov M., Shah R. G., Salvesen G. S. et al. (2001) Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis. J. Biol. Chem. 276: 2935-2942
20. Tong W. M., Hande M. P., Lansdorp P. M. and Wang Z. Q. (2001) DNA strand break-sensing molecule poly(ADP-ribose) polymerase cooperates with p53 in telomere function, chromosome stability and tumor suppression. Mol. Cell. Biol. 21: 4046-4054
21. de Murcia J. M., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M. et al. (1997) Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proc. Natl. Acad. Sci. USA 94: 7303-7307
22. Wang Z. Q., Stingl L., Morrison C., Jantsch M., Los M., Schulze-Osthoff K. et al. (1997) PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11: 2347-2358
23. Trucco C., Oliver F. J., de Murcia G. and Menissier-de Murcia J. (1998) DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Res. 26: 2644-2649
24. Busuttil R. A., Rubio M., Dolle M. E., Campisi J. and Vijg J. (2003) Oxygen accelerates the accumulation of mutations during the senescence and immortalization of murine cells in culture. Aging Cell 2: 287-294
25. Yang Y. G., Cortes U., Patnaik S., Jasin M. and Wang Z. Q. (2004) Ablation of PARP-1 does not interfere with the repair of DNA double-strand breaks, but compromises the reactivation of stalled replication forks. Oncogene 23: 3872-3882
26. Buerkle A., Schreiber V., Dantzer F., Oliver F. J., Niedergang C. and de Murcia G. et al. (2000) Biological significance of poly(ADP-ribosyl)ation reactions: molecular and genetic approaches. In: From DNA Damage and Stress Signaling to Cell Death. PolyADP-Ribosylation Reactions, pp. 80-124, de Murcia G. and Shall S. (eds), Oxford University Press, New York
27. Shibata A., Kamada N., Masumura K., Nohmi T., Kobayashi S., Teraoka H. et al. (2005) Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agnet. Oncogene, in press
28. Malanga M. and Althaus F. R. (2004) Poly(ADP-ribose) reactivates stalled DNA topoisomerase I and induces DNA strand break resealing. J. Biol. Chem. 279: 5244-5248
29. Menissier de Murcia J., Ricoul M., Tartier L., Niedergang C., Huber A., Dantzer F. et al. (2003) Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J. 22: 2255-2263
30. Augustin A., Spenlehauer C., Dumond H., Menissier-De Murcia J., Piel M., Schmit A. C. et al. (2003) PARP-3 localizes preferentially to the daughter centriole and interferes with the G1/S cell cycle progression. J. Cell Sci. 116: 1551-1562
31. Gunji A., Fujihara H., Kamada N., Omura K., Jishage K., Nakagama H. et al. (2003) Lack of altered frequency of sister-chromatid exchanges in poly(ADP-ribose) glycohydrolase-deficient mouse ES cells treated with methylmethanesulfonate, Proc. Jpn. Acad. 79 Ser. B: 305-307
32. Nozaki T., Fujihara H., Gunji A., Shibata A., Kamada N., Jishage K. et al. (2002) Increased sensitivity of poly(ADP-ribose) glycohydrolase-deficient ES cell lines to alkylating agent and gamma-irradiation. Cancer Sci. 93 Suppl.: 51
33. Gunji A., Fujihara H., Kamada N., Jishage K., Omura K., Nakagama H. et al. (2003) Early induction and increase of apoptotic cells in Parp-/- ES cells after methylmethanesulfonate treatment. Cancer Sci. 94 Suppl.: 93
34. Cortes U., Tong W. M., Coyle D. L., Meyer-Ficca M. L., Meyer R. G., Petrilli V. et al. (2004) Depletion of the 110-kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice. Mol. Cell. Biol. 24: 7163-7178
35. Dynek J. N. and Smith S. (2004) Resolution of sister telomere association is required for progression through mitosis. Science 304: 97-100
36. Zardo G., Reale A., Passananti C., Pradhan S., Buontempo S., De Matteis G. et al. (2002) Inhibition of poly(ADP-ribosyl)ation induces DNA hypermethylation: a possible molecular mechanism. FASEB. J. 16: 1319-1321
37. Tulin A. and Spradling A. (2003) Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci. Science 299: 560-562
38. Beneke R. and Moroy T. (2001) Inhibition of poly(ADP-ribose) polymerase activity accelerates T-cell lymphomagenesis in p53 deficient mice. Oncogene 20: 8136-8141
39. Tong W. M., Cortes U., Hande M. P., Ohgaki H., Cavalli L. R., Lansdorp P. M. et al. (2002) Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation. Cancer Res. 62: 6990-6996
40. Tsutsumi M., Masutani M., Nozaki T., Kusuoka O., Tsujiuchi T., Nakagama H. et al. (2001) Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis 22: 1-3
41. Nozaki T., Fujihara H., Watanabe M., Tsutsumi M., Nakamoto K., Kusuoka O. et al. (2003) Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane. Cancer Sci. 94: 497-500
42. Morrison C., Smith G. C., Stingl L., Jackson S. P., Wagner E. F. and Wang Z. Q. (1997) Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis. Nat. Genet. 17: 479-482
43. Tong W. M., Ohgaki H., Huang H., Granier C., Kleihues P. and Wang Z. Q. (2003) Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) Mice. Am. J. Pathol. 162: 343-352
44. Conde C., Mark M., Oliver F. J., Huber A., de Murcia G. and Menissier-de Murcia J. (2001) Loss of poly(ADP-ribose) polymerase-1 causes increased tumour latency in p53-deficient mice. EMBO J. 20: 3535-3543
45. Ambs S., Ogunfusika M. O., Merriam W. G., Bennett W. P., Billiar T. R., and Harris C. C. (1998) Up-regulation of inducible nitric oxide synthase expression in cancer-prone p53 knockout mice. Proc. Natl. Acad. Sci. USA 95: 8823-8828
46. Martin-Oliva D., O'Valle F., Munoz-Gamez J. A., Valenzuela M. T., Nunez M. I., Aguilar M. et al. (2004) Crosstalk between PARP-1 and NF-kappaB modulates the promotion of skin neoplasia. Oncogene 23: 6684-6692
47. Masutani M., Gunji A., Kamada N., Watanabe M., Jishage K., Nakagama H. et al. (2004) Involvement of poly(ADP-ribose) glycohydrolase in recovery from DNA damage response and modulation of apoptosis. Proc. Am. Assoc. Cancer Res. 45:1146
48. Hanai S., Kanai M., Ohashi S., Okamoto K., Yamada M., Takahashi H. et al. (2004) Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 101: 82-86
49. Ohashi Y., Ueda K., Hayaishi O., Ikai K. and Niwa O. (1984) Induction of murine teratocarcinoma cell differentiation by suppression of poly(ADP-ribose) synthesis. Proc. Natl. Acad. Sci. USA 81: 7132-7136
50. Terada M., Fujiki H., Marks P. A. and Sugimura T. (1979) Induction of erythroid differentiation of murine erythroleukemia cells by nicotinamide and related compounds. Proc. Natl. Acad. Sci. USA 76: 6411-6414
51. Shima H., Nakayasu M., Aonuma S., Sugimura T. and Nagao M. (1989) Loss of the MYC gene amplified in human HL-60 cells after treatment with inhibitors of poly(ADP-ribose) polymerase or with dimethyl sulfoxide. Proc. Natl. Acad. Sci. USA 86: 7442-7445
52. Bauer P. I., Kirsten E., Varadi G., Young L. J., Hakam A., Comstock J. A. et al. (1995) Reversion of malignant phenotype by 5-iodo-6-amino-1,2- benzopyrone a non-covalently binding ligand of poly(ADP-ribose) polymerase. Biochimie 77: 374-377
53. Hans M. A., Muller M., Meyer-Ficca M., Buerkle A. and Kupper J. H. (1999) Overexpression of dominant negative PARP interferes with tumor formation of HeLa cells in nude mice: evidence for increased tumor cell apoptosis in vivo. Oncogene 18: 7010-7015
54. Nozaki T., Masutani M., Watanabe M., Ochiya T., Hasegawa F., Nakagama H. et al. (1999) Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 96: 13345-13350
55. Hemberger M., Nozaki T., Winterhager E., Yamamoto H., Nakagama H., Kamada N. et al. (2003) Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev. Biol. 257: 371-381
56. von Hochstetter A. R., Sigg C., Saremaslani P. and Hedinger C. (1985) The significance of giant cells in human testicular seminomas. A clinico-pathological study. Virchows Arch. A. Pathol. Anat. Histopathol. 407: 309-322
57. Auer B., Nagl U., Herzog H., Schneider R. and Schweiger M. (1989) Human nuclear NAD+ ADP-ribosyltransferase(polymerizing): organization of the gene. DNA 8: 575-580
58. Prasad S. C., Thraves P. J., Bhatia K. G., Smulson M. E. and Dritschilo A. (1990) Enhanced poly(adenosine diphosphate ribose) polymerase activity and gene expression in Ewing's sarcoma cells. Cancer Res. 50: 38-43
59. Soldatenkov V. A., Albor A., Patel B. K., Dreszer R., Dritschilo A. and Notario V. (1999) Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor. Oncogene 18: 3954-3962
60. Ogura T., Nyunoya H., Takahashi-Masutani M., Miwa M., Sugimura T. and Esumi H. (1990) Characterization of a putative promoter region of the human poly(ADP-ribose) polymerase gene: structural similarity to that of the DNA polymerase beta gene. Biochem. Biophys. Res. Commun. 167: 701-710
61. Oei S. L., Herzog H., Hirsch-Kauffmann M., Schneider R., Auer B. and Schweiger M. (1994) Transcriptional regulation and autoregulation of the human gene for ADP-ribosyltransferase. Mol. Cell Biochem. 138: 99-104
62. Schweiger M., Oei S. L., Herzog H., Menardi C., Schneider R., Auer B. et al. (1995) Regulation of the human poly(ADP-ribosyl) transferase promoter via alternative DNA racket structures. Biochimie 77: 480-485
63. Bieche I., de Murcia G. and Lidereau R. (1996) Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin. Cancer Res. 2: 1163-1167
64. Masutani M., Nozaki T., Sasaki H., Yamada T., Kohno T., Shimizu K. et al. (2004) Aberration of poly(ADP-ribose)-polymerase-1 gene in human tumor cell lines: its expression and structural alterations. Proc. Jpn. Acad. 80 Ser. B: 114-118
65. Shiokawa M., Masutani M., Ueki K., Nishikawa R., Sugimura T., Kubo H. et al. (2005) Genetic alteration of poly(ADP-ribose) polymerase-1 in human germ cell tumors. Jpn. J. Clin. Oncol., in press
66. Idogawa M., Yamada T., Honda K., Imai K. and Hirohashi S. (2004) Proteomic analysis of the T-cell factor (TCF)-4/b-catenin transcriptional complex. Proc. Am. Assoc. Cancer Res. 45: 817
67. min/+ mice by targeting the nitric oxide or poly(ADP-ribose) pathways. Mutat. Res. 548: 107-116
68. Ghabreau L., Roux J. P., Frappart P. O., Mathevet P., Patricot L. M., Mokni M. et al. (2004) Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int. J. Cancer 109: 317-321
69. Lokett K. L., Hall M. C., Xu J., Zheng S. L., Berwick M., Chuang S. C. (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res. 64: 6344-6348
70. Abdel-Aziz W., Malkas L., Hoelz D. and Hickey R. (2004) A modified form of poly(ADP-ribose) polymerase (PARP) is present in breast cancer cells. Proc. Am. Assoc. Cancer Res. 45: 606
71. Bhatia K. G., Cherney B. W., Huppi K., Magrath I. T., Cossman J., Sausville E. et al. (1990) A deletion linked to a poly(ADP-ribose) polymerase gene on chromosome 13q33-qter occurs frequently in the normal black population as well as in multiple tumor DNA. Cancer Res. 50: 5406-5413
72. Bhatia K., Huppi K., Cherney B., Raffeld M., Smulson M. and Magrath I. (1990) Relative predispositional effect of a PADPRP marker allele in B-cell and some non B-cell malignancies. Curr. Top Microbiol. Immunol. 166: 347-357
73. Lyn D., Cherney B. W., Lalande M., Berenson J. R., Lichtenstein A., Lupold S. et al. (1993) A duplicated region is responsible for the poly(ADP-ribose) polymerase polymorphism, on chromosome 13, associated with a predisposition to cancer. Am. J. Hum. Genet. 52: 124-134
74. Shimokawa T., Masutani M., Nozaki T., Nakagama H., Araki S., Aoki Y. et al. (1998) The human poly(ADP-ribose) glycohydrolase maps to chromosome 10q11.23-21.1 by fluorescence in situ hybridization. Human Cell 11: 243-246
75. Calabrese C. R., Almassy R., Barton S., Batey M. A., Calvert A. H., Canan-Koch S. et al. (2004) Anticancer chemosensitization and radiosensitization by the novel poly(ADP-ribose) polymerase-1 inhibitor AG14361. J. Natl. Cancer. Inst. 96: 56-67
76. Curtin N. J., Wang L. Z., Yiakouvaki A., Kyle S., Arris C. A., Canan-Koch S. et al. (2004) Novel poly(ADP-ribose) polymerase-1 inhibitor, AG14361, restores sensitivity to temozolomide in mismatch repair-deficient cells. Clin. Cancer Res. 10: 881-889
77. Slama J. T., Aboul-Ela N., Goli D. M., Cheesman B. V., Simmons A. M. and Jacobson M. K. (1995) Specific inhibition of poly(ADP-ribose) glycohydrolase by adenosine diphosphate (hydroxymethyl)pyrrolidinediol. J. Med. Chem. 38: 389-393
78. Coyle D. L., Kim H., Jacobson E. L. and Jacobson M. K. (2003) Synthesis and characterizaton of potent and selective cell permeable inhibitors of poly(ADP-ribose) glycohydrolase. Med. Sci. Mon. 9 Suppl. 1: 15
79. Masutani M., Shimokawa T., Igarashi M., Hamada M., Shibata A., Oami S. et al. (2002) Inhibition of poly(ADP-ribose) glycohydrolase activity by cyclic peptide antibiotics containing piperazic acid residues. Proc. Jpn. Acad. 78 Ser. B: 15-17
80. Kanai Y., Isonishi S. and Terashima Y. (1989) Antibody to poly(ADP-ribose) is an indicator of obstetric complications in pregnant patients with systemic lupus erythematosus. Immunol. Lett. 21: 217-222
81. Isonishi S. and Kanai Y. (1988) Antibody to poly(ADP-ribose) as a predictor of obstetric complications in autoimmune MRL/Mp-lpr/lpr mice: basis for its application to pregnant patients with systemic lupus erythematosus. Immunol. Lett. 18: 61-66
82. Yamauchi S. and Kanai Y (1991) Preferential suppression of antibody to poly(ADP-ribose) in lupus-prone MRL/Mp-lpr/lpr mice by benadrostin. Jikeikai Medical J. 38: 387-393
83. Miesel R., Kurpisz M. and Kroger H. (1995) Modulation of inflammatory arthritis by inhibition of poly(ADP ribose) polymerase. Inflammation 19: 379-387
84. Kroger H., Miesel R., Dietrich A., Ohde M., Rajnavolgyi E. and Ockenfels H. (1996) Synergistic effects of thalidomide and poly (ADP-ribose) polymerase inhibition on type II collagen-induced arthritis in mice. Inflammation 20: 203-215
85. Zingarelli B., Salzman A. L. and Szabo C. (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ. Res. 83: 85-94
86. Scott G. S., Hake P., Kean R. B., Virag L., Szabo C. and Hooper D. C. (2001) Role of poly(ADP-ribose) synthetase activation in the development of experimental allergic encephalomyelitis. J. Neuroimmunol. 117: 78-86
87. Suarez-Pinzon W. L., Mabley J. G., Power R., Szabo C. and Rabinovitch A. (2003) Poly (ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes. Diabetes 52: 1683-1688
88. Jawaheer D., Seldin M. F., Amos C. I., Chen W. V., Shigeta R., Monteiro J. et al. (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68: 927-936
89. Pascual M., Lopez-Nevot M. A., Caliz R., Ferrer M. A., Balsa A., Pascual-Salcedo D. et al. (2003) A poly(ADP-ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis. Arthritis Rheum. 48: 638-641
90. Kolb H. and Burkart V. (1999) Nicotinamide in type 1 diabetes. Mechanism of action revisited. Diabetes Care 22 Suppl. 2B: 16-20
91. Burkart V., Wang Z. Q., Radons J., Heller B., Herceg Z., Stingl L. et al. (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozotocin. Nat. Med. 5: 314-319
92. Masutani M., Suzuki H., Kamada N., Watanabe M., Ueda O., Nozaki T. et al. (1999) Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96: 2301-2304
93. Pieper A. A., Brat D. J., Krug D. K., Watkins C. C., Gupta A., Blackshaw S. et al. (1999) Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. USA 96: 3059-3064
94. Suarez-Pinzon W. L., Mabley J. G., Power R., Szabo C. and Rabinovitch A. (2003) Poly(ADP-ribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes. Diabetes 52: 1683-1688
95. Nistico L., Buzzetti R., Pritchard L. E., Van der Auwera B., Giovannini C., Bosi E. et al. (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry, Hum. Mol. Genet. 5: 1075-1080
96. Delrieu O., Dubois-Laforgue D., Timsit J., Tournier-Lasserve E. and Caillat-Zucman S. (2001) A dinucleotide repeat polymorphism at the poly(ADP-ribose) polymerase gene is not associated with predisposition to type 1 diabetes in French Caucasians. J. Autoimmun. 17: 137-140
97. Tsao B. P., Cantor R. M., Grossman J. M., Shen N., Teophilov N. T. and Wallace D. J. (1999) PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J. Clin. Invest. 103: 1135-1140
98. Criswell L. A., Moser K. L., Gaffney P. M., Inda S., Ortmann W. A., Lin D. et al. (2000) PARP alleles and SLE: failure to confirm association with disease susceptibility. J. Clin. Invest. 105: 1501-1502
99. Yamamoto H. and Okamoto H. (1980) Protection by picolinamide, a novel inhibitor of poly (ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Biochem. Biophys. Res. Commun. 95: 474-481
100. Yamagami T., Miwa A., Takasawa S., Yamamoto H. and Okamoto H. (1985) Induction of rat pancreatic B-cell tumors by the combined administration of streptozotocin or alloxan and poly(adenosine diphosphate ribose) synthetase inhibitors. Cancer Res. 45: 1845-1849
101. Anderson M. G., Scoggin K. E., Simbulan-Rosenthal C. M. and Steadman J. A. (2000) Identification of poly(ADP-ribose) polymerase as a transcriptional coactivator of the human T-cell leukemia virus type 1 Tax protein. J. Virol. 74: 2169-2177
102. Lee D., Kim J. W., Kim K., Joe C. O., Schreiber V., Menissier-De Murcia J. et al. (2002) Functional interaction between human papillomavirus type 18 E2 and poly(ADP-ribose) polymerase 1. Oncogene 21: 5877-5885
103. Boyonoski A. C., Spronck J. C., Gallacher L. M., Jacobs R. M., Shah G. M., Poirier G. G. et al. (2002) Niacin deficiency decreases bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. J. Nutr. 132: 108-114
104. Boyonoski A. C., Spronck J. C., Jacobs R. M., Shah G. M., Poirier G. G. and Kirkland J. B. (2002) Pharmacological intakes of niacin increase bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats J. Nutr. 132: 115-120
105. Albert M. L. and Darnell R. B. (2004) Paraneoplastic neurological degenerations: keys to tumour immunity. Nat. Rev. Cancer 4: 36-44
106. Darnell R. B. and DeAngelis L. M. (1993) Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341: 21-22
107. Soldatenkov V. A., Chasovskikh S., Potaman V. N., Trofimova I., Smulson M. E. and Dritschilo A. (2002) Transcriptional repression by binding of poly(ADP-ribose) polymerase to promoter sequences. J. Biol. Chem. 277: 665-670
108. Simbulan-Rosenthal C. M., Haddad B. R., Rosenthal D. S., Weaver Z., Coleman A., Luo R. et al. (1999) Chromosomal aberrations in PARP(-/-) mice: genome stabilization in immortalized cells by reintroduction of poly(ADP-ribose) polymerase cDNA. Proc. Natl. Acad. Sci. USA 96: 13191-13196
109. Nozaki T., Fujihara H., Kamada N., Ueda O., Takato T., Nakagama H. et al. (2001) Hyperploidy of embryonic fibroblasts derived from Parp-1 knockout mouse. Proc. Jpn. Acad. 77 Ser. B: 121-124